Implicit|||||||||||Expansion|||||||||||0..298|0|Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4 + T cells from patients with rheumatoid arthritis Abstract IL-10 has been shown to block the antigen-specific T-cell cytokine response by inhibiting the CD28 signaling pathway .||||||||300..634|1|We found that peripheral blood CD4 + T cells from patients with active rheumatoid arthritis ( RA ) were able to produce greater amounts of interferon gamma after CD3 and CD28 costimulation in the presence of 1 ng/ml IL-10 than were normal control CD4 + T cells , although their surface expression of the type 1 IL-10 receptor was increased .|||||||||||||
Implicit|||||||||||Expansion|||||||||||300..634|1|We found that peripheral blood CD4 + T cells from patients with active rheumatoid arthritis ( RA ) were able to produce greater amounts of interferon gamma after CD3 and CD28 costimulation in the presence of 1 ng/ml IL-10 than were normal control CD4 + T cells , although their surface expression of the type 1 IL-10 receptor was increased .||||||||636..835|2|The phosphorylation of signal transducer and activator of transcription 3 was sustained in both blood and synovial tissue CD4 + T cells of RA , but it was not augmented by the presence of 1 ng/ml IL-10 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||636..835|2|The phosphorylation of signal transducer and activator of transcription 3 was sustained in both blood and synovial tissue CD4 + T cells of RA , but it was not augmented by the presence of 1 ng/ml IL-10 .||||||||837..1019|3|Sera from RA patients induced signal transducer and activator of transcription 3 phosphorylation in normal CD4 + T cells , which was mostly abolished by neutralizing anti-IL-6 antibody .|||||||||||||
EntRel||||||||||||||||||||||837..1019|3|Sera from RA patients induced signal transducer and activator of transcription 3 phosphorylation in normal CD4 + T cells , which was mostly abolished by neutralizing anti-IL-6 antibody .||||||||1021..1132|4|Preincubation of normal CD4 + T cells with IL-6 reduced IL-10-mediated inhibition of interferon gamma production .|||||||||||||
EntRel||||||||||||||||||||||1021..1132|4|Preincubation of normal CD4 + T cells with IL-6 reduced IL-10-mediated inhibition of interferon gamma production .||||||||1134..1358|5|Blood CD4 + T cells from RA patients contained higher levels of suppressor of cytokine signaling 1 but lower levels of suppressor of cytokine signaling 3 mRNA compared with control CD4 + T cells , as determined by real-time PCR .|||||||||||||
EntRel||||||||||||||||||||||1681..1834|7|Introduction IL-10 is a key cytokine in regulating inflammatory responses , mainly by inhibiting the production and function of proinflammatory cytokines .||||||||1836..2027|8|IL-10 binds to the IL-10 receptor ( IL-10R ) complex that is composed of two subunits , the primary ligand-binding component type 1 IL-10R ( IL-10R1 ) and the accessory component type 2 IL-10R [ 1 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1836..2027|8|IL-10 binds to the IL-10 receptor ( IL-10R ) complex that is composed of two subunits , the primary ligand-binding component type 1 IL-10R ( IL-10R1 ) and the accessory component type 2 IL-10R [ 1 ] .||||||||2029..2219|9|The interaction of IL-10 and IL-10R engages the Janus kinase ( JAK ) family tyrosine kinases Jak1 and Tyk2 , which are constitutively associated with IL-10R1 and type 2 IL-10R , respectively [ 2 ] .|||||||||||||
EntRel||||||||||||||||||||||2029..2219|9|The interaction of IL-10 and IL-10R engages the Janus kinase ( JAK ) family tyrosine kinases Jak1 and Tyk2 , which are constitutively associated with IL-10R1 and type 2 IL-10R , respectively [ 2 ] .||||||||2221..2384|10|IL-10 induces tyrosine phosphorylation and activation of the latent transcriptional factors signal transducer and activator of transcription ( STAT ) 3 and STAT1 [ 3 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2221..2384|10|IL-10 induces tyrosine phosphorylation and activation of the latent transcriptional factors signal transducer and activator of transcription ( STAT ) 3 and STAT1 [ 3 ] .||||||||2386..2535|11|Upon phosphorylation , STAT1 and STAT3 proteins form homodimers or heterodimers , rapidly translocate into the nucleus , and modulate gene transcription .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2386..2535|11|Upon phosphorylation , STAT1 and STAT3 proteins form homodimers or heterodimers , rapidly translocate into the nucleus , and modulate gene transcription .||||||||2537..2661|12|Intriguingly , STAT3 is indispensable for both IL-10-derived anti-inflammatory and IL-6-derived proinflammatory responses [ 4 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2537..2661|12|Intriguingly , STAT3 is indispensable for both IL-10-derived anti-inflammatory and IL-6-derived proinflammatory responses [ 4 ] .||||||||2663..2918|13|Studies of cell-type-specific STAT3-deficient mice have shown that STAT3 activation is essential for IL-10-mediated anti-inflammatory reactions in macrophages and neutrophils [ 5 ] , but is responsible for IL-6-mediated prevention of apoptosis in T cells [ 6 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2663..2918|13|Studies of cell-type-specific STAT3-deficient mice have shown that STAT3 activation is essential for IL-10-mediated anti-inflammatory reactions in macrophages and neutrophils [ 5 ] , but is responsible for IL-6-mediated prevention of apoptosis in T cells [ 6 ] .||||||||2920..3213|14|The suppressor of cytokine signaling ( SOCS ) proteins have been identified as a family of endogenous JAK kinase inhibitors that can act in classic feedback inhibition loops , but their roles as the mediators of crosstalk inhibition by opposing cytokine signaling pathways have been clarified [ 7 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3215..3414|15|Recent studies indicate that SOCS3 plays a key role in regulating the divergent action of IL-10 and IL-6 , by specifically blocking STAT3 activation induced by IL-6 but not that induced by IL-10 [ 8,9 ] .||||||||3418..3655|16|The synovial membrane of rheumatoid arthritis ( RA ) is characterized by an infiltrate of a variety of inflammatory cells , such as lymphocytes , macrophages , and dendritic cells , together with proliferation of synovial fibroblast-like cells .|||||||||||||
EntRel||||||||||||||||||||||3418..3655|16|The synovial membrane of rheumatoid arthritis ( RA ) is characterized by an infiltrate of a variety of inflammatory cells , such as lymphocytes , macrophages , and dendritic cells , together with proliferation of synovial fibroblast-like cells .||||||||3657..3809|17|Numerous cytokines are overproduced in the inflamed joint , and macrophages and synovial fibroblasts are an important source of proinflammatory cytokines .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3657..3809|17|Numerous cytokines are overproduced in the inflamed joint , and macrophages and synovial fibroblasts are an important source of proinflammatory cytokines .||||||||3811..4137|18|Tumor necrosis factor alpha ( TNF-α ) and IL-1 , two major macrophage products , are crucial in the process of chronic inflammation and joint destruction , and they give rise to effector components , including other inflammatory cytokines , chemokines , growth factors , matrix proteases , nitric oxide , and reactive oxygen species [ 10 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4408..4518|20|However , anti-inflammatory cytokines and cytokine inhibitors are also present in large quantities in RA joints .||||||||4520..4771|21|IL-10 , produced by macrophages and partly by T cells in the synovial tissue ( ST ) , is best known as a negative regulator for macrophage and Th1 cells , but the expression level is insufficient to counterbalance the cascade of proinflammatory events [ 12 ] .|||||||||||||
EntRel||||||||||||||||||||||4773..4911|22|In addition , the anti-inflammatory action of IL-10 appears to be modulated at the level of signal transduction during chronic inflammation .||||||||4913..5058|23|IL-10 signaling is impaired in macrophages upon chronic exposure to proinflammatory cytokines such as TNF-α and IL-1 and immune complexes [ 13,14 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5060..5235|24|Cell surface expression of IL-10R1 is decreased in synovial fluid dendritic cells due to the presence of TNF-α , IL-1 , and granulocyte – macrophage colony-stimulating factor [ 15 ] .||||||||5239..5360|25|CD4 + T cells may be activated by arthritogenic antigens , in conjunction with CD28-mediated costimulatory signaling , in RA .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5239..5360|25|CD4 + T cells may be activated by arthritogenic antigens , in conjunction with CD28-mediated costimulatory signaling , in RA .||||||||5362..5674|26|The significance of this autoimmune process has been supported by the linkage of the MHC class II antigens HLA-DRB1 * 0404 and HLA-DRB1 * 0401 with disease susceptibility and severity [ 16,17 ] , and by the high-level expression of MHC class II molecules and both CD28 ligands , CD80 and CD86 , in the inflamed ST [ 18-20 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5362..5674|26|The significance of this autoimmune process has been supported by the linkage of the MHC class II antigens HLA-DRB1 * 0404 and HLA-DRB1 * 0401 with disease susceptibility and severity [ 16,17 ] , and by the high-level expression of MHC class II molecules and both CD28 ligands , CD80 and CD86 , in the inflamed ST [ 18-20 ] .||||||||5676..6016|27|The continuing emergence of activated CD4 + T cells , even though few in number , may be crucial in sustaining the activation of macrophages and synovial fibroblasts through cell surface signaling by means of cell surface CD69 and CD11 , as well as the release of proinflammatory Th1 cytokines such as interferon gamma ( IFN ) - γ and IL-17 [ 21,22 ] .|||||||||||||
EntRel||||||||||||||||||||||6164..6483|29|Their obligatory role in RA synovitis was recently proved by successful treatment of active disease by selective inhibition of T-cell activation with fusion protein of cytotoxic T-cell-associated antigen 4 ( CD152 ) - IgG , which can block the engagement of CD28 on T cells by binding to CD80 and CD86 with high avidity [ 23 ] .||||||||6487..6685|30|IL-10 efficiently blocks the antigen-specific T-cell cytokine response by inhibiting the CD28 signaling pathway [ 24 ] , as well as indirectly by downregulating the function of antigen-presenting cells .|||||||||||||
EntRel||||||||||||||||||||||7023..7324|32|Materials and methods The total patient population consisted of 32 patients with RA ( 25 women and seven men ; mean ± standard deviation age , 52.8 ± 12.4 years ) diagnosed according to the revised 1987 criteria of the American College of Rheumatology ( formally , the American Rheumatism Association ) [ 25 ] .||||||||7326..7423|33|All patients were receiving prednisolone ( ≤ 7.5 mg/day ) and disease-modifying antirheumatic drugs .|||||||||||||
Implicit|||||||||||Expansion|||||||||||7326..7423|33|All patients were receiving prednisolone ( ≤ 7.5 mg/day ) and disease-modifying antirheumatic drugs .||||||||7425..7674|34|Clinical parameters in the study patients were as follows ( mean ± standard deviation ) : erythrocyte sedimentation rate , 55.9 ± 35.4 mm/hour ; serum C-reactive protein ( CRP ) level , 32.0 ± 32.0 mg/l ; and IgM class rheumatoid factor titer , 142 ± 158 U/ml .|||||||||||||
EntRel||||||||||||||||||||||7425..7674|34|Clinical parameters in the study patients were as follows ( mean ± standard deviation ) : erythrocyte sedimentation rate , 55.9 ± 35.4 mm/hour ; serum C-reactive protein ( CRP ) level , 32.0 ± 32.0 mg/l ; and IgM class rheumatoid factor titer , 142 ± 158 U/ml .||||||||7676..7977|35|Patients were divided into two groups : 24 patients with active disease , who had multiple tender and/or swollen joints and elevated serum CRP level ( ≥ 10 mg/l ) ; and eight patients with inactive disease , who satisfied the American College of Rheumatology preliminary criteria for clinical remission [ 26 ] .|||||||||||||
EntRel||||||||||||||||||||||7676..7977|35|Patients were divided into two groups : 24 patients with active disease , who had multiple tender and/or swollen joints and elevated serum CRP level ( ≥ 10 mg/l ) ; and eight patients with inactive disease , who satisfied the American College of Rheumatology preliminary criteria for clinical remission [ 26 ] .||||||||7979..8072|36|Sixteen healthy volunteers ( 11 women and five men ; age , 45.8 ± 11.2 years ) served as controls .|||||||||||||
EntRel||||||||||||||||||||||7979..8072|36|Sixteen healthy volunteers ( 11 women and five men ; age , 45.8 ± 11.2 years ) served as controls .||||||||8074..8155|37|ST samples were obtained from three RA patients undergoing total knee replacement .|||||||||||||
EntRel||||||||||||||||||||||8157..8191|38|All patients gave informed consent .||||||||8195..8366|39|Peripheral blood mononuclear cells ( PBMC ) were prepared from heparinized blood samples by centrifugation over Ficoll-Hypaque density gradients ( Pharmacia , Uppsala , Sweden ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8195..8366|39|Peripheral blood mononuclear cells ( PBMC ) were prepared from heparinized blood samples by centrifugation over Ficoll-Hypaque density gradients ( Pharmacia , Uppsala , Sweden ) .||||||||8368..8550|40|CD4 + T cells were purified from PBMC by positive selection using anti-CD4 mAb-coated magnetic beads ( Miltenyi Biotec , Gladbach , Germany ) , according to the manufacturer 's instructions .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8368..8550|40|CD4 + T cells were purified from PBMC by positive selection using anti-CD4 mAb-coated magnetic beads ( Miltenyi Biotec , Gladbach , Germany ) , according to the manufacturer 's instructions .||||||||8552..8624|41|CD4 + T cells were isolated from ST samples , as previously described [ 27 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8552..8624|41|CD4 + T cells were isolated from ST samples , as previously described [ 27 ] .||||||||8626..8726|42|Briefly , fresh ST samples were fragmented and digested with collagenase and DNase for 1 hour at 37 ° C .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8626..8726|42|Briefly , fresh ST samples were fragmented and digested with collagenase and DNase for 1 hour at 37 ° C .||||||||8728..9135|43|After removing tissue debris , ST cell suspensions in culture medium ( RPMI 1640 medium ; Life Technologies , Gaithersburg , MD , USA ) supplemented with 25 mM HEPES ( 2 mM L-glutamine , 2 % nonessential amino acids , 100 IU/ml penicillin , and 100 mg/ml streptomycin ; Life Technologies ) with 10 % heat-inactivated FCS ( Life Technologies ) were incubated at 37 ° C in six-well plates ( Coster , Cambridge , MA , USA ) for 45 min .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9137..9244|44|Non-adherent cells were harvested and CD4 + T cells were purified by positive selection as already described .||||||||9248..9517|45|PB CD4 + T-cell populations were resuspended at a density of 1 × 106 cells/ml in culture medium with 10 % FCS , and 0.5 ml cell suspensions were dispensed into the wells of 24-well microtiter plates ( Coster ) coated with 1 μg / ml anti-CD3 mAb ( Immunotech , Marseille , France ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9248..9517|45|PB CD4 + T-cell populations were resuspended at a density of 1 × 106 cells/ml in culture medium with 10 % FCS , and 0.5 ml cell suspensions were dispensed into the wells of 24-well microtiter plates ( Coster ) coated with 1 μg / ml anti-CD3 mAb ( Immunotech , Marseille , France ) .||||||||9519..9747|46|The cells were incubated with 1 μg / ml anti-CD28 mAb ( Immunotech ) in the presence or absence of the indicated concentrations of IL-10 ( Becton Dickinson , San Jose , CA , USA ) at 37 ° C in a humidified atmosphere containing 5 % CO2 [ 28 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9749..9863|47|Culture supernatants were collected 36 hours later and cell-free samples were stored at -30 ° C until cytokine assay .||||||||9867..10088|48|To examine the effect of IL-6 on T-cell responsiveness to IL-10 , CD4 + T cells from healthy controls were incubated in culture medium with 10 % FCS in the presence or absence of 10 ng/ml IL-6 ( Becton Dickinson ) for 36 hours .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9749..9810|50|Culture supernatants were measured for IFN-γ concentrations .||||||||10274..10342|51|A sample of 5 × 105 cells of PBMC was resuspended in PBS with 1 % FCS .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10274..10342|51|A sample of 5 × 105 cells of PBMC was resuspended in PBS with 1 % FCS .||||||||10344..10641|52|PBMC were incubated with saturating concentrations of anti-IL-10R1 mAb ( IgG1 ; R&D systems , Minneapolis , MN , USA ) or with isotype-matched control mAb ( Immunotech ) , followed by incubation with FITC-conjugated goat anti-mouse IgG1 polyclonal antibody ( Santa Cruz Biotechnologies , Santa Cruz , CA , USA ) .|||||||||||||
EntRel||||||||||||||||||||||10643..10730|53|Cells were then incubated with phycoerythrin-conjugated anti-CD4 mAb ( Becton Dickinson ) .||||||||10732..10790|54|Cells were washed well with 1 % FCS/PBS between incubations .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10792..10861|55|Analysis was performed on a FACScan flow cytometer ( Becton Dickinson ) .||||||||10865..11167|56|Concentrations of IFN-γ and IL-2 in culture supernatants of CD4 + T cells were measured in duplicate by the quantitative sandwich ELISA using cytokine-specific capture with biotinylated detection mAb and recombinant cytokine proteins ( all from Becton Dickinson ) , according to the manufacturer 's protocol .|||||||||||||
EntRel||||||||||||||||||||||11169..11222|57|The detection limits for IFN-γ and IL-2 were 15 pg/ml .||||||||11226..11397|58|Total cellular RNA was extracted from PB CD4 + T cells using an RNA isolation kit ( RNeasy Mini kit ; Qiagen , Valencia , CA , USA ) , according to the manufacturer 's instructions .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11226..11397|58|Total cellular RNA was extracted from PB CD4 + T cells using an RNA isolation kit ( RNeasy Mini kit ; Qiagen , Valencia , CA , USA ) , according to the manufacturer 's instructions .||||||||11399..11580|59|cDNA was synthesized from total RNA with Molony murine leukemia virus reverse transcriptase ( US Biochemical , Cleveland , OH , USA ) and oligo - ( dT ) 15 primers ( Promega , Madison , WI , USA ) .|||||||||||||
EntRel||||||||||||||||||||||11399..11580|59|cDNA was synthesized from total RNA with Molony murine leukemia virus reverse transcriptase ( US Biochemical , Cleveland , OH , USA ) and oligo - ( dT ) 15 primers ( Promega , Madison , WI , USA ) .||||||||11582..11701|60|Real-time PCR was performed with the LightCycler Instrument ( Roche Diagnostics , Penzberg , Germany ) in glass capillaries .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11703..11914|61|The reaction mix containing Taq DNA polymerase and DNA double-strand-specific SYBR Green I dye ( Lightcycler FastStart DNA Master SYBR Green I ; Roche Diagnostics ) and specific primers were added to cDNA dilutions .||||||||11918..12209|62|The cDNA samples were denatured at 95 ° C for 10 min , and were then amplified for 40 – 50 cycles : at 95 ° C ( 10 s ) , at 65 ° C ( 15 s ) , and 72 ° C ( 22 s ) for β-actin ; at 95 ° C ( 10 s ) , at 62 ° C ( 15 s ) , and at 72 ° C ( 10 s ) for SOCS1 ; and at 96 ° C ( 10 s ) , at 68 ° C ( 15 s ) , and at 72 ° C ( 15 s ) for SOCS3 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12211..12341|63|Amplification curves of the fluorescence values versus cycle number were obtained , and a melting curve analysis was then performed .||||||||12343..12445|64|The levels of SOCS1 and SOCS3 expression were determined by normalizing relative to β-actin expression .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12447..12712|65|The forward and reverse primers were as follows : for β-actin , 5 ' - GTGGGGCGCCCCAGGCACCA-3 ' and 5 ' - CTCCTTAATGTCACGCACGATTTC-3 ' ; for SOCS1 , 5 ' - AGACCCCTTCTCACCTCTTG-3 ' and 5 ' - GCACAGCAGAAAAATAAAGC-3 ' ; and for SOCS3 , 5 ' - CCCGCCGGCACCTTTCTG-3 ' and 5 ' - AGGGGCCGGCTCAACACC-3 ' .||||||||12716..12873|66|CD4 + T cells were stimulated for 20 min by the indicated concentrations of IL-10 and IL-6 at a density of 5 × 105 cells in 0.5 ml culture medium with 10 % FCS .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12716..12873|66|CD4 + T cells were stimulated for 20 min by the indicated concentrations of IL-10 and IL-6 at a density of 5 × 105 cells in 0.5 ml culture medium with 10 % FCS .||||||||9867..10146|67|To examine the effect of serum IL-6 on STAT phosphorylation , normal CD4 + T cells were stimulated for 20 min with 30 % active RA serum in culture medium with 40 μg / ml neutralizing goat anti-IL-6 polyclonal antibody ( IgG ; Techne , Princeton , NJ , USA ) or control goat IgG ( Techne ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9867..10146|67|To examine the effect of serum IL-6 on STAT phosphorylation , normal CD4 + T cells were stimulated for 20 min with 30 % active RA serum in culture medium with 40 μg / ml neutralizing goat anti-IL-6 polyclonal antibody ( IgG ; Techne , Princeton , NJ , USA ) or control goat IgG ( Techne ) .||||||||13152..13323|68|Whole cell lysates were prepared by placing cells in 100 μl SDS lysing buffer ( 62.5 mM Tris – HCl [ pH 6.8 ] , 2 % SDS , 10 % glycerol , 50 mM dithiothreitol , 0.1 % bromphenol blue ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13325..13572|69|Then 20 μl protein samples were fractionated on 10 % SDS-polyacrylamide gels and were transferred to nitrocellulose membranes ( Amersham , Buckinghamshire , UK ) , and the membrane was blocked with 5 % skim milk in Tris-buffered saline with 0.1 % Tween 20 .||||||||13576..13755|70|Tyrosine phosphorylation of STAT1 and STAT3 was detected using commercial available kits ( Cell Signaling Technology , Beverly , MA , USA ) according to the manufacturer 's instructions .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13576..13755|70|Tyrosine phosphorylation of STAT1 and STAT3 was detected using commercial available kits ( Cell Signaling Technology , Beverly , MA , USA ) according to the manufacturer 's instructions .||||||||13757..14065|71|Briefly , the membrane was incubated with the antibodies ( rabbit IgG ) anti-STAT1 antibody , anti-phosphorylated tyrosine 701 of STAT1 antibody , anti-STAT3 antibody , and anti-phosphorylated tyrosine 705 of STAT3 antibody , diluted as recommended at 1/2000 with Tris-buffered saline with 0.1 % Tween 20 with 5 % BSA .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13757..14065|71|Briefly , the membrane was incubated with the antibodies ( rabbit IgG ) anti-STAT1 antibody , anti-phosphorylated tyrosine 701 of STAT1 antibody , anti-STAT3 antibody , and anti-phosphorylated tyrosine 705 of STAT3 antibody , diluted as recommended at 1/2000 with Tris-buffered saline with 0.1 % Tween 20 with 5 % BSA .||||||||14067..14286|72|Antibody binding was detected by horseradish peroxidase-conjugated anti-rabbit IgG antibody diluted at 1/4000 with Tris-buffered saline with 0.1 % Tween 20 with 5 % BSA , and was revealed using the chemiluminescence system .|||||||||||||
EntRel||||||||||||||||||||||14067..14286|72|Antibody binding was detected by horseradish peroxidase-conjugated anti-rabbit IgG antibody diluted at 1/4000 with Tris-buffered saline with 0.1 % Tween 20 with 5 % BSA , and was revealed using the chemiluminescence system .||||||||14288..14435|73|Protein bands were quantified by densitometry using NIH-Image analysis , and STAT phosphorylation was compared with the total amount of STAT protein .|||||||||||||
EntRel||||||||||||||||||||||14437..14523|74|IFN-γ-stimulated Hela cells were used as a positive control for STAT1 phosophorylation .||||||||14527..14605|75|Data are expressed as the mean value ± standard error of the mean or box plots .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14527..14605|75|Data are expressed as the mean value ± standard error of the mean or box plots .||||||||14607..14744|76|The statistical significance of differences between two groups was determined by the Mann – Whitney U test or the Wilcoxon signed rank test .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14785..15034|78|Results The CD28 costimulatory pathway is crucial for effective antigen-specific T-cell cytokine production , and IL-10 can directly suppress this response by inhibiting CD28 tyrosine phosphorylation and binding of phosphatidylinositol 3-kinase [ 24 ] .||||||||15036..15364|79|To evaluate the responsiveness of RA CD4 + T cells to IL-10 , purified PB CD4 + T cells from three patients with active RA and from three healthy controls were stimulated by immobilized anti-CD3 antibody and anti-CD28 antibody with or without diluted concentrations of IL-10 for 36 hours , and IFN-γ production was measured by ELISA .|||||||||||||
Implicit|||||||||||Expansion|||||||||||15036..15364|79|To evaluate the responsiveness of RA CD4 + T cells to IL-10 , purified PB CD4 + T cells from three patients with active RA and from three healthy controls were stimulated by immobilized anti-CD3 antibody and anti-CD28 antibody with or without diluted concentrations of IL-10 for 36 hours , and IFN-γ production was measured by ELISA .||||||||15366..15498|80|As shown in Fig. 1 , IFN-γ production by activated normal CD4 + T cells was mostly inhibited at concentrations as low as 1 ng/ml IL-10 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||15694..15996|82|We thus compared the levels of IFN-γ production by CD4 + T cells after CD3 and CD28 costimulation in the presence of 1 ng/ml IL-10 in RA patients with active disease ( multiple inflammatory joints , CRP level ≥ 10 mg/l ) and inactive disease ( in remission , CRP level < 10 mg/l ) [ 26 ] and in healthy controls .||||||||15998..16389|83|There were no statistically significant differences in IFN-γ production without IL-10 among these three groups ( Fig. 2a ) , but the inhibitory effect of IL-10 on IFN-γ production was significantly limited in the active RA group as compared with the inactive RA group and healthy controls ( percentage decrease : active RA , 2.9 ± 14.4 % ; inactive RA , 45.6 ± 14.4 % ; controls , 65.8 ± 7.9 % ) ( Fig. 2b ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16909..17056|87|Taken together , these results indicate that RA CD4 + T cells become less susceptible to the immunoregulatory effect of IL-10 during the active phase .||||||||17060..17217|88|The functional receptor complex of IL-10 consists of two subunits , the primary ligand-binding component IL-10R1 and the accessory component type 2 IL-10R [ 1 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17060..17217|88|The functional receptor complex of IL-10 consists of two subunits , the primary ligand-binding component IL-10R1 and the accessory component type 2 IL-10R [ 1 ] .||||||||17219..17295|89|IL-10R1 expression plays a critical role in cellular responses to IL-10 [ 29 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17219..17295|89|IL-10R1 expression plays a critical role in cellular responses to IL-10 [ 29 ] .||||||||17297..17560|90|To examine whether the resistance to IL-10 inhibition in RA CD4 + T cells was due to limited receptor expression , the cell surface expression of IL-10R1 on PB CD4 + T cells from active RA patients and from healthy controls was determined by flow cytometric analysis .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17297..17560|90|To examine whether the resistance to IL-10 inhibition in RA CD4 + T cells was due to limited receptor expression , the cell surface expression of IL-10R1 on PB CD4 + T cells from active RA patients and from healthy controls was determined by flow cytometric analysis .||||||||17562..17714|91|As shown in Fig. 3a ,3 b , the intensity of IL-10R1 expression on CD4 + T cells was significantly increased in RA patients compared with in healthy controls .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17716..17842|92|These results suggest that the intracellular signal transduction pathway of IL-10 may be impaired in CD4 + T cells of active RA .||||||||2029..2171|93|The interaction of IL-10R with IL-10 induces tyrosine phosphorylation and activation of the latent transcription factors STAT1 and STAT3 [ 3 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2029..2171|93|The interaction of IL-10R with IL-10 induces tyrosine phosphorylation and activation of the latent transcription factors STAT1 and STAT3 [ 3 ] .||||||||17988..18238|94|Macrophage-specific STAT3-deficient mice demonstrated that STAT3 plays a dominant role in IL-10-mediated anti-inflammatory responses [ 5 ] , which has recently been confirmed in human macrophages by studies of dominant-negative STAT3 overexpression [ 30 ] .|||||||||||||
EntRel||||||||||||||||||||||17988..18238|94|Macrophage-specific STAT3-deficient mice demonstrated that STAT3 plays a dominant role in IL-10-mediated anti-inflammatory responses [ 5 ] , which has recently been confirmed in human macrophages by studies of dominant-negative STAT3 overexpression [ 30 ] .||||||||18240..18402|95|The induction of STAT1 and STAT3 phosphorylation by IL-10 in PB CD4 + T cells from active RA patients and from healthy controls was examined using western blotting .|||||||||||||
Implicit|||||||||||Expansion|||||||||||18240..18402|95|The induction of STAT1 and STAT3 phosphorylation by IL-10 in PB CD4 + T cells from active RA patients and from healthy controls was examined using western blotting .||||||||6890..7014|96|STAT3 phosphorylation was dose-dependently induced after IL-10 activation for 20 min in normal CD4 + T cells ( Fig. 4a ,4 b ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||18526..18678|97|In contrast , STAT3 was phosphorylated in freshly isolated PB CD4 + cells from RA patients and this STAT3 phosphorylation was detectable for up to 6 hours .||||||||6890..6974|98|STAT3 phosphorylation was augmented only when activated by as much as 10 ng/ml IL-10 .|||||||||||||
EntRel||||||||||||||||||||||6890..6974|98|STAT3 phosphorylation was augmented only when activated by as much as 10 ng/ml IL-10 .||||||||18766..18895|99|Both sustained STAT3 phosphorylation and defective IL-10-induced STAT3 phosphorylation were found in RA ST CD4 + T cells ( Fig. 4c ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1360..1564|101|These results indicate that STAT3 is the major IL-10-activated STAT in CD4 + T cells , and IL-10-induced STAT3 activation may be diminished in active RA , in association with sustained STAT3 phosphorylation .||||||||19236..19638|102|STAT3 is activated by many cytokines and growth factors such as the IL-6 family of cytokines ( IL-6 , IL-11 , leukemia inhibitory factor , and oncostatin M ) , platelet-derived growth factor , and epidermal growth factor , in addition to IL-10 [ 4 ] , but previous studies have demonstrated that IL-6 is the major factor in RA synovial fluid that induces constitutive activation of STAT3 in mononuclear cells [ 31 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||19640..19950|103|Since IL-6 is also abundant in sera of active RA patients , frequently detected at > 1 ng/ml [ 27 ] , we examined whether persistent exposure of CD4 + T cells to high concentrations of IL-6 in the blood circulation was responsible for their sustained STAT3 activation and resistance to IL-10 inhibition in active RA .||||||||19952..20095|104|Both STAT1 and STAT3 phosphorylation was activated by IL-6 in normal CD4 + T cells ( data not shown ) , in agreement with previous observations [ 4 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||20097..20332|105|Normal CD4 + T cells were thus incubated for 20 min with culture medium containing 30 % serum from active RA patients and neutralizing anti-IL-6 antibody or control antibody , and STAT phosphorylation was examined by western blot analysis .||||||||20334..20502|106|RA serum was able to induce tyrosine phosphorylation of STAT3 but not STAT1 , and this STAT3 activation was mostly abolished by neutralization of IL-6 activity ( Fig. 5a ) .|||||||||||||
EntRel||||||||||||||||||||||20334..20502|106|RA serum was able to induce tyrosine phosphorylation of STAT3 but not STAT1 , and this STAT3 activation was mostly abolished by neutralization of IL-6 activity ( Fig. 5a ) .||||||||1360..1473|107|These results indicate that IL-6 is the dominant STAT3-activating factor contained in sera of active RA patients .|||||||||||||
Implicit|||||||||||Expansion|||||||||||20848..20956|109|We next examined whether IL-6 could suppress the effect of IL-10 to inhibit IFN-γ production by CD4 + T cells .||||||||20958..21192|110|After preincubation with or without 10 ng/ml IL-6 for 36 hours , normal CD4 + T cells were stimulated by CD3 and CD28 costimulation in the presence or absence of 1 ng/ml IL-10 for 36 hours , and the IFN-γ production was measured by ELISA .|||||||||||||
Implicit|||||||||||Expansion|||||||||||20958..21192|110|After preincubation with or without 10 ng/ml IL-6 for 36 hours , normal CD4 + T cells were stimulated by CD3 and CD28 costimulation in the presence or absence of 1 ng/ml IL-10 for 36 hours , and the IFN-γ production was measured by ELISA .||||||||21194..21382|111|IL-6 pretreatment of normal cells reduced IL-10-mediated inhibition of IFN-γ production ( Fig. 5b ) , indicating that high concentrations of IL-6 could modulate T-cell responsiveness to IL-10 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16909..17114|112|Taken together , these findings suggest that persistent exposure to serum IL-6 may have a role in both the induction of STAT3 activation and the resistance to the inhibitory effect of IL-10 in RA CD4 + T cells .||||||||21595..21829|113|IL-6 induces two potent inhibitors of JAKs ( SOCS1 and SOCS3 proteins ) that not only act as mediators of negative feedback inhibition , but also play a major role in crosstalk inhibition by opposing other cytokine-signaling pathways [ 7 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||21595..21829|113|IL-6 induces two potent inhibitors of JAKs ( SOCS1 and SOCS3 proteins ) that not only act as mediators of negative feedback inhibition , but also play a major role in crosstalk inhibition by opposing other cytokine-signaling pathways [ 7 ] .||||||||21831..21999|114|SOCS3 has recently been shown to specifically inhibit STAT3 activation induced by IL-6 but not by IL-10 , thereby regulating the divergent action of IL-6 and IL-10 [ 8,9 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22001..22156|115|On the contrary , SOCS1 is able to partially inhibit IL-10-mediated STAT3 activation and cellular responses , as well as IFN-γ-mediated STAT1 activation [ 32 ] .||||||||22158..22429|116|To determine whether SOCSs were involved in the defective IL-10-induced STAT3 activation of RA CD4 + T cells , the levels of SOCS1 and SOCS3 mRNA expression in PB CD4 + T cells from active RA patients and from healthy controls were compared by semiquantitative real-time PCR .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22158..22429|116|To determine whether SOCSs were involved in the defective IL-10-induced STAT3 activation of RA CD4 + T cells , the levels of SOCS1 and SOCS3 mRNA expression in PB CD4 + T cells from active RA patients and from healthy controls were compared by semiquantitative real-time PCR .||||||||22431..22561|117|The RA CD4 + T cells contained higher levels of SOCS1 but lower levels of SOCS3 transcripts than did control CD4 + T cells ( Fig. 6a ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22431..22561|117|The RA CD4 + T cells contained higher levels of SOCS1 but lower levels of SOCS3 transcripts than did control CD4 + T cells ( Fig. 6a ) .||||||||22563..22755|118|Constitutive expression of SOCS1 mRNA in RA CD4 + T cells was comparable with the expression in normal CD4 + T cells stimulated by 10 ng/ml IL-6 ( Fig. 6b ) , supporting its functional significance .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22890..22980|120|Discussion CD4 + T cells orchestrate the Th1-type cell-mediated immune response in RA [ 22 ] .||||||||22982..23222|121|Activated CD4 + T cells stimulate macrophages , synovial fibroblasts , B cells , and osteoclasts through the expression of cell surface molecules and Th1 cytokines , thereby contributing to both the chronic inflammation and the joint destruction .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22982..23222|121|Activated CD4 + T cells stimulate macrophages , synovial fibroblasts , B cells , and osteoclasts through the expression of cell surface molecules and Th1 cytokines , thereby contributing to both the chronic inflammation and the joint destruction .||||||||23224..23332|122|CD4 + T cells require two signals to be activated ; antigen receptor occupancy and CD28-mediated costimulation .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23224..23332|122|CD4 + T cells require two signals to be activated ; antigen receptor occupancy and CD28-mediated costimulation .||||||||23334..23530|123|In the ST lesion , the CD28 ligands , both CD80 and CD86 , together with MHC class II antigens , are substantially expressed by antigen-presenting cells such as macrophages and dendritic cells [ 18-20 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23532..23741|124|The significance of CD28 engagement in the T-cell-mediated disease process has recently been proven by the clinical efficacy of its blocker cytotoxic T-cell-associated antigen 4 ( CD152 ) - IgG in RA patients [ 23 ] .||||||||23745..23886|125|IL-10 plays a predominant role in limiting immune and inflammatory responses by regulating the function of both macrophages and Th1 cells [ 1 ] .|||||||||||||
EntRel||||||||||||||||||||||23745..23886|125|IL-10 plays a predominant role in limiting immune and inflammatory responses by regulating the function of both macrophages and Th1 cells [ 1 ] .||||||||23888..24063|126|IL-10 inhibits the tyrosine phosphorylation of the CD28 molecule and the subsequent phosphatidylinositol 3-kinase binding in T cells , and thereby directly acts on T cells [ 24 ] .|||||||||||||
Implicit|||||||||||Contingency|||||||||||23888..24063|126|IL-10 inhibits the tyrosine phosphorylation of the CD28 molecule and the subsequent phosphatidylinositol 3-kinase binding in T cells , and thereby directly acts on T cells [ 24 ] .||||||||24065..24273|127|In the present study , we found that PB CD4 + T cells from patients with active RA , in the presence of IL-10 , are able to produce higher levels of IFN-γ after CD3 and CD28 costimulation than normal CD4 + T cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24065..24273|127|In the present study , we found that PB CD4 + T cells from patients with active RA , in the presence of IL-10 , are able to produce higher levels of IFN-γ after CD3 and CD28 costimulation than normal CD4 + T cells .||||||||24275..24532|128|Despite high-level IL-10R1 expression and constitutive STAT3 activation , IL-10-induced tyrosine phosphorylation of STAT3 is suppressed in RA CD4 + T cells , in contrast to normal CD4 + T cells , where STAT3 phosphorylation is dose-dependently inducible by IL-10 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24275..24532|128|Despite high-level IL-10R1 expression and constitutive STAT3 activation , IL-10-induced tyrosine phosphorylation of STAT3 is suppressed in RA CD4 + T cells , in contrast to normal CD4 + T cells , where STAT3 phosphorylation is dose-dependently inducible by IL-10 .||||||||24534..24711|129|Serum IL-6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4 + T cells , and exogenous IL-6 induces the resistance to IL-10 inhibition of IFN-γ production .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24534..24711|129|Serum IL-6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4 + T cells , and exogenous IL-6 induces the resistance to IL-10 inhibition of IFN-γ production .||||||||22435..22567|130|RA CD4 + T cells contain higher levels of SOCS1 but contain lower levels of SOCS3 transcripts in comparison with normal CD4 + T cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24846..25148|131|These findings indicate that CD4 + T cells become resistant to the inhibitory effect of IL-10 before migration into the inflamed ST , and suggest that this resistance may be attributable to impaired IL-10-dependent STAT3 activation , in association with sustained STAT3 phosphorylation and SOCS1 induction .||||||||1076..1234|132|IL-10-mediated inhibition of CD4 + T-cell cytokine production is principally dependent on its inhibition of macrophage antigen-presenting cell function [ 1 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25308..25542|133|However , this indirect inhibitory effect is thought to be restricted at the site of T-cell activation in RA , because macrophages in the ST express high levels of cytokines , CD80 and CD86 molecules , and MHC class II antigens [ 10,18-20 ] .||||||||25544..25683|134|More recently , IL-10 has been shown to induce the antigen-specific T-cell unresponsiveness by inhibiting CD28 tyrosine phosphorylation [ 33 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25685..25867|135|This direct effect also may be limited in active RA patients , because their PB CD4 + T cells showed a defective IL-10 inhibition of CD28-costimulated production of both IFN-γ and IL-2 .||||||||25871..26061|136|Numerous cytokines , both proinflammatory and anti-inflammatory , have been detected in the ST of RA , and the balance between these opposing cytokine activities regulates disease severity [ 10 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25871..26061|136|Numerous cytokines , both proinflammatory and anti-inflammatory , have been detected in the ST of RA , and the balance between these opposing cytokine activities regulates disease severity [ 10 ] .||||||||26063..26186|137|Endogenous IL-10 , produced mainly by macrophages and T cells , inhibits proinflammatory cytokine production by ST cells [ 12 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26188..26272|138|However , this regulatory activity seems to be restricted during chronic inflammation .||||||||26274..26487|139|The activation of both the extracellular stimulus-regulated kinase and p38 kinase pathways , induced by TNF-α and IL-1 , inhibits the Jak1 – STAT3 signaling pathway shared by IL-10 and IL-6 in adhered macrophages [ 13 ] .|||||||||||||
EntRel||||||||||||||||||||||26274..26487|139|The activation of both the extracellular stimulus-regulated kinase and p38 kinase pathways , induced by TNF-α and IL-1 , inhibits the Jak1 – STAT3 signaling pathway shared by IL-10 and IL-6 in adhered macrophages [ 13 ] .||||||||26489..26588|140|More importantly , IL-10-mediated STAT3 activation is mostly undetectable in RA synovial macrophages .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26489..26588|140|More importantly , IL-10-mediated STAT3 activation is mostly undetectable in RA synovial macrophages .||||||||26590..26903|141|This impaired IL-10 signaling is probably induced by chronic exposure to immune complexes in vivo , because both cell surface IL-10R1 expression and IL-10-induced Jak1 activation are suppressed in IFN-γ-primed macrophages by a protein kinase C-dependent pathway following ligation of the IgG Fc gamma receptor [ 14 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26905..27194|142|Furthermore , dendritic cells from RA synovial fluids are resistant to the immunoregulatory effect of IL-10 due to decreased transport of intracellular IL-10R1 in the presence of proinflammatory cytokine stimuli such as TNF-α , IL-1 , and granulocyte – macrophage colony-stimulating factor [ 15 ] .||||||||27196..27363|143|We have demonstrated that the resistance of RA CD4 + T cells to IL-10 may be associated with defective IL-10-dependent STAT3 activation , but not with IL-10R1 expression .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27365..27538|144|Inhibitory effects of IL-10 on these inflammatory cell types are therefore differentially modulated at the signal transduction level under the inflammatory environment in RA .||||||||27542..27738|145|In association with impaired IL-10-mediated STAT3 activation , STAT3 was found to be tyrosine phosphorylated persistently ( up to 6 hours ) in freshly isolated PB and ST CD4 + T cells from RA patients .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27542..27738|145|In association with impaired IL-10-mediated STAT3 activation , STAT3 was found to be tyrosine phosphorylated persistently ( up to 6 hours ) in freshly isolated PB and ST CD4 + T cells from RA patients .||||||||27740..27932|146|STAT3 is activated by a variety of cytokines , notably the IL-6 family of cytokines ( e.g. IL-6 , IL-11 , leukemia inhibitory factor , and oncostatin M ) and growth factors , in addition to IL-10 [ 4 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27740..27932|146|STAT3 is activated by a variety of cytokines , notably the IL-6 family of cytokines ( e.g. IL-6 , IL-11 , leukemia inhibitory factor , and oncostatin M ) and growth factors , in addition to IL-10 [ 4 ] .||||||||27934..28121|147|Of these cytokines , IL-6 plays a predominant role in eliciting a systemic reaction such as the acute phase response in active RA , due mainly to its abundance in the blood circulation [ 27 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27934..28121|147|Of these cytokines , IL-6 plays a predominant role in eliciting a systemic reaction such as the acute phase response in active RA , due mainly to its abundance in the blood circulation [ 27 ] .||||||||28123..28349|148|Consistent with this notion , IL-6 was the major STAT3-activating factor contained in the serum of active RA patients , and the responsiveness to IL-10 was suppressed in normal CD4 + T cells after 36 hours of incubation with IL-6 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||28123..28349|148|Consistent with this notion , IL-6 was the major STAT3-activating factor contained in the serum of active RA patients , and the responsiveness to IL-10 was suppressed in normal CD4 + T cells after 36 hours of incubation with IL-6 .||||||||17716..17924|149|These results suggest that both the sustained STAT3 activation and the resistance to IL-10 inhibition found in RA CD4 + T cells may be induced after chronic exposure in vivo to high concentrations of serum IL-6 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||28839..28944|151|CD4 + T cells isolated from the ST of RA also showed a defect in the IL-10-induced STAT3 signaling pathway .||||||||28946..29141|152|It is most probable that the resistance of CD4 + T cells to IL-10 can be even augmented after migration into the inflamed ST , because IL-6 is highly concentrated compared with the blood level [ 27 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29452..29635|154|Furthermore , IFN-γ and IL-10 produced by CD4 + T cells themselves could be responsible for impaired IL-10 signaling in the ST , because T-cell infiltrates produce both cytokines [ 34,35 ] .||||||||29637..29795|155|In an autocrine fashion , IL-10 may persistently stimulate STAT3 activation and IFN-γ can induce SOCS1 protein as a crosstalk inhibitor of IL-10 signaling [ 32 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29797..29986|156|The T-cell-inhibitory effect of IL-10 may therefore be modulated complicatedly upon exposure to an inflammatory environment in RA joints , where many cytokines are present substantially [ 10 ] .||||||||29990..30052|157|STAT3 activation has been implicated in the pathogenesis of RA .|||||||||||||
EntRel||||||||||||||||||||||29990..30052|157|STAT3 activation has been implicated in the pathogenesis of RA .||||||||30054..30152|158|Active STAT3 is constitutively expressed in synovial fluid mononuclear cells from RA patients [ 36 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||30054..30152|158|Active STAT3 is constitutively expressed in synovial fluid mononuclear cells from RA patients [ 36 ] .||||||||30154..30375|159|IL-6 is the major STAT3-activating factor present in synovial fluid , which has a crucial role in the activation of monocyte functions such as gene expression of the Fc gamma receptor type I and type III and of HLA-DR [ 31 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||30154..30375|159|IL-6 is the major STAT3-activating factor present in synovial fluid , which has a crucial role in the activation of monocyte functions such as gene expression of the Fc gamma receptor type I and type III and of HLA-DR [ 31 ] .||||||||30377..30604|160|More recently , high levels of activated STAT3 , thought to be induced mainly by IL-6 , have been detected in the ST , and STAT3 activation has been shown to be involved in synovial fibroblast proliferation and IL-6 production [ 37 ] .|||||||||||||
EntRel||||||||||||||||||||||30377..30604|160|More recently , high levels of activated STAT3 , thought to be induced mainly by IL-6 , have been detected in the ST , and STAT3 activation has been shown to be involved in synovial fibroblast proliferation and IL-6 production [ 37 ] .||||||||30606..30722|161|In this regard , STAT3 is critical in the survival and expansion of growth factor-dependent synovial fibroblasts [ 38 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||31077..31263|163|In the gp130F759/F759 mice , T cells , particularly the CD4 + T-cell subset , are chronically activated and resistant to activation-induced cell death through gp130-mediated STAT3 activation .||||||||31267..31380|164|The longevity of cytokine signals transduced by the JAK – STAT pathway is regulated by the SOCS family proteins [ 7 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||31267..31380|164|The longevity of cytokine signals transduced by the JAK – STAT pathway is regulated by the SOCS family proteins [ 7 ] .||||||||31382..31532|165|We found that CD4 + T cells from patients with active RA expressed higher levels of SOCS1 , but lower levels of SOCS3 , compared with normal CD4 + T cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||31382..31532|165|We found that CD4 + T cells from patients with active RA expressed higher levels of SOCS1 , but lower levels of SOCS3 , compared with normal CD4 + T cells .||||||||31534..31723|166|SOCS1 prevents activation of JAK by directly binding to JAK , and SOCS3 inhibits the action of JAK by binding to the Src homology phosphatase-2-binding domain of receptors such as gp130 [ 40 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||31534..31723|166|SOCS1 prevents activation of JAK by directly binding to JAK , and SOCS3 inhibits the action of JAK by binding to the Src homology phosphatase-2-binding domain of receptors such as gp130 [ 40 ] .||||||||31725..31863|167|SOCS1 and SOCS3 are induced by various cytokines , including IL-6 and IL-10 , as mediators of negative feedback and crosstalk inhibition [ 7 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||31725..31863|167|SOCS1 and SOCS3 are induced by various cytokines , including IL-6 and IL-10 , as mediators of negative feedback and crosstalk inhibition [ 7 ] .||||||||31865..32001|168|Recent studies with mice lacking SOCS3 or SOCS1 revealed that SOCS3 is a negative regulator of IL-6 signaling but not of IL-10 signaling .|||||||||||||
Implicit|||||||||||Expansion|||||||||||31865..32001|168|Recent studies with mice lacking SOCS3 or SOCS1 revealed that SOCS3 is a negative regulator of IL-6 signaling but not of IL-10 signaling .||||||||32003..32174|169|Studies of conditional SOCS3-deficient mice have shown that SOCS3 deficiency , but not SOCS1 deficiency , results in sustained activation of STAT3 in response to IL-6 [ 8,41 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||32003..32174|169|Studies of conditional SOCS3-deficient mice have shown that SOCS3 deficiency , but not SOCS1 deficiency , results in sustained activation of STAT3 in response to IL-6 [ 8,41 ] .||||||||32176..32317|170|The analysis of SOCS3-deficient macrophages has indicated that SOCS3 is a crucial inhibitor of the IL-6-induced transcriptional response [ 42 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||32537..32805|173|Increased SOCS1 expression in RA CD4 + T cells may therefore be associated with both the impaired responsiveness to IL-10 and to IL-10-mediated STAT3 activation , and defective SOCS3 expression may be responsible for persistent STAT3 activation in response to serum IL-6 .||||||||32809..33085|174|There is a possibility that SOCS1 induction may be associated with the ability of CD4 + T cells to produce IFN-γ , because CD4 + T cells from active RA could produce high levels of IFN-γ in the presence of IL-10 , and because IFN-γ has been known as a potent inducer of SOCS1 [ 32 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||32809..33085|174|There is a possibility that SOCS1 induction may be associated with the ability of CD4 + T cells to produce IFN-γ , because CD4 + T cells from active RA could produce high levels of IFN-γ in the presence of IL-10 , and because IFN-γ has been known as a potent inducer of SOCS1 [ 32 ] .||||||||33087..33227|175|It is of interest in this regard to indicate that polarized Th1 and Th2 cells express high levels of SOCS1 and SOCS3 mRNA , respectively [ 44 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||33087..33227|175|It is of interest in this regard to indicate that polarized Th1 and Th2 cells express high levels of SOCS1 and SOCS3 mRNA , respectively [ 44 ] .||||||||33229..33388|176|IL-12-induced STAT4 activation is inhibited by SOCS3 induction in Th2 cells , whereas IL-4-induced STAT6 signaling is diminished by SOCS1 induction in Th1 cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||33390..33582|177|SOCS1 and SOCS3 may thus have important roles as Th1-specific and Th2-specific , mutually exclusive , cross-talk repressors of the IL-4 – STAT6 and the IL-12 – STAT4 signaling pathways , respectively .||||||||28123..28349|178|Consistent with this notion , PB T cells from patients with allergic diseases significantly express high levels of SOCS3 transcripts , and the SOCS3 expression correlates well with serum IgE levels and disease pathology [ 45 ] .|||||||||||||
EntRel||||||||||||||||||||||34059..34273|180|Conclusion CD4 + T cells from active RA patients are characterized by their resistance to IL-10 inhibition of IFN-γ production , due to constitutive STAT3 phosphorylation and impaired IL-10-mediated STAT3 activation .||||||||34275..34362|181|The defective STAT3 signaling is possibly associated with SOCS1 predominance over SOCS3 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||34275..34362|181|The defective STAT3 signaling is possibly associated with SOCS1 predominance over SOCS3 .||||||||34364..34483|182|These abnormalities in active RA are thought to be induced mainly after chronic exposure to high concentrations of IL-6 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||34364..34483|182|These abnormalities in active RA are thought to be induced mainly after chronic exposure to high concentrations of IL-6 .||||||||34485..34643|183|The limited efficacy of IL-10 treatment of RA patients [ 50 ] may be explained in part by the unresponsiveness to IL-10 of inflammatory cells , including T cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||35894..36004|188|Authors ' contributions Jiro Yamana was responsible for the experiments and data analysis and wrote the report .||||||||36006..36100|189|Masahiro Yamamura was responsible for the planning of the research and wrote up the manuscript .|||||||||||||
EntRel||||||||||||||||||||||36006..36100|189|Masahiro Yamamura was responsible for the planning of the research and wrote up the manuscript .||||||||36102..36196|190|Akira Okamoto , Tetsushi Aita , Mitsuhiro Iwahashi , and Katsue Sunahori assisted the experiments .|||||||||||||
Implicit|||||||||||Expansion|||||||||||36248..36478|192|Figure and Table captions Figure 1 : Dose response of IL-10 inhibition of interferon gamma ( IFN-γ ) production by CD4 + T cells after CD3 and CD28 costimulation in patients with rheumatoid arthritis ( RA ) and in healthy controls ( HC ) .||||||||8368..8510|193|CD4 + T cells were purified from peripheral blood mononuclear cells of three RA patients and three HC by positive selection with anti-CD4 antibody .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8368..8510|193|CD4 + T cells were purified from peripheral blood mononuclear cells of three RA patients and three HC by positive selection with anti-CD4 antibody .||||||||36627..36837|194|CD4 + T cells ( 5 × 105 cells in 0.5 ml culture medium with 10 % FCS ) were stimulated by immobilized anti-CD3 antibody and anti-CD28 antibody in the presence or absence of diluted IL-10 concentrations for 36 hours .|||||||||||||
Implicit|||||||||||Expansion|||||||||||36627..36837|194|CD4 + T cells ( 5 × 105 cells in 0.5 ml culture medium with 10 % FCS ) were stimulated by immobilized anti-CD3 antibody and anti-CD28 antibody in the presence or absence of diluted IL-10 concentrations for 36 hours .||||||||9749..9820|195|Culture supernatants were measured for concentrations of IFN-γ by ELISA .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9749..9820|195|Culture supernatants were measured for concentrations of IFN-γ by ELISA .||||||||16053..16128|196|IFN-γ production with IL-10 expressed as % IFN-γ production without IL-10 .|||||||||||||
EntRel||||||||||||||||||||||36987..37035|197|Values are the mean ± standard error of the mean .||||||||37038..37226|198|Figure 2 : ( a ) Interferon gamma ( IFN-γ ) production by CD3 and CD28 costimulated CD4 + T cells in the presence of IL-10 in patients with rheumatoid arthritis ( RA ) and in healthy controls ( HC ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||37038..37226|198|Figure 2 : ( a ) Interferon gamma ( IFN-γ ) production by CD3 and CD28 costimulated CD4 + T cells in the presence of IL-10 in patients with rheumatoid arthritis ( RA ) and in healthy controls ( HC ) .||||||||36627..36782|199|CD4 + T cells ( 5 × 105 cells in 0.5 ml culture medium with 10 % FCS ) were stimulated by anti-CD3 antibody and anti-CD28 antibody with or without 1 ng/ml IL-10 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||36627..36782|199|CD4 + T cells ( 5 × 105 cells in 0.5 ml culture medium with 10 % FCS ) were stimulated by anti-CD3 antibody and anti-CD28 antibody with or without 1 ng/ml IL-10 .||||||||10865..10950|200|Concentrations of IFN-γ in culture supernatants were measured in duplicate by ELISA .|||||||||||||
EntRel||||||||||||||||||||||10865..10950|200|Concentrations of IFN-γ in culture supernatants were measured in duplicate by ELISA .||||||||37471..37640|201|RA patients were divided into those with active disease ( multiple inflammatory joints and CRP level ≥ 10 mg/l ) and inactive disease ( in remission and CRP level ≤ 4 mg/l ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||37471..37640|201|RA patients were divided into those with active disease ( multiple inflammatory joints and CRP level ≥ 10 mg/l ) and inactive disease ( in remission and CRP level ≤ 4 mg/l ) .||||||||37642..37832|202|The results are represented as a box plot ; upper and lower bars , 90th and 10th percentiles , respectively ; upper , center and lower lines of box , 75th , 50th , and 25th percentiles , respectively .|||||||||||||
Implicit|||||||||||Expansion|||||||||||37642..37832|202|The results are represented as a box plot ; upper and lower bars , 90th and 10th percentiles , respectively ; upper , center and lower lines of box , 75th , 50th , and 25th percentiles , respectively .||||||||37834..37868|203|( b ) Percentage of IFN-γ production .|||||||||||||
Implicit|||||||||||Expansion|||||||||||37834..37868|203|( b ) Percentage of IFN-γ production .||||||||16053..16128|204|IFN-γ production with IL-10 expressed as % IFN-γ production without IL-10 .|||||||||||||
EntRel||||||||||||||||||||||16053..16128|204|IFN-γ production with IL-10 expressed as % IFN-γ production without IL-10 .||||||||36987..37035|205|Values are the mean ± standard error of the mean .|||||||||||||
EntRel||||||||||||||||||||||37995..38022|206|n , number of samples tested .||||||||38025..38198|207|Figure 3 : ( a ) Cell surface expression of type 1 interleukin-10 receptor ( IL-10R1 ) on CD4 + T cells from patients with rheumatoid arthritis ( RA ) and from healthy controls ( HC ) .|||||||||||||
EntRel||||||||||||||||||||||38025..38198|207|Figure 3 : ( a ) Cell surface expression of type 1 interleukin-10 receptor ( IL-10R1 ) on CD4 + T cells from patients with rheumatoid arthritis ( RA ) and from healthy controls ( HC ) .||||||||8195..8465|208|Peripheral blood mononuclear cells were stained with anti-IL-10R1 antibody or with isotype-matched control antibody , followed by incubation with FITC-conjugated goat anti-mouse IgG1 polyclonal antibody , and were then stained with phycoerythrin-conjugated anti-CD4 mAb .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8195..8465|208|Peripheral blood mononuclear cells were stained with anti-IL-10R1 antibody or with isotype-matched control antibody , followed by incubation with FITC-conjugated goat anti-mouse IgG1 polyclonal antibody , and were then stained with phycoerythrin-conjugated anti-CD4 mAb .||||||||38469..38545|209|The expression of CD4 and IL-10R1 was determined by flow cytometric analysis .|||||||||||||
EntRel||||||||||||||||||||||38469..38545|209|The expression of CD4 and IL-10R1 was determined by flow cytometric analysis .||||||||38547..38655|210|Representative histographic patterns of IL-10R1 expression on CD4 + T cells from RA patients and HC are shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||38547..38655|210|Representative histographic patterns of IL-10R1 expression on CD4 + T cells from RA patients and HC are shown .||||||||38657..38819|211|( b ) The intensity of IL-10R1 on CD4 + T cells was expressed as the ratio of the mean fluorescence intensity ( MFI ) of staining with anti-IL-10R1 to control antibody .|||||||||||||
EntRel||||||||||||||||||||||38657..38819|211|( b ) The intensity of IL-10R1 on CD4 + T cells was expressed as the ratio of the mean fluorescence intensity ( MFI ) of staining with anti-IL-10R1 to control antibody .||||||||36987..37035|212|Values are the mean ± standard error of the mean .|||||||||||||
EntRel||||||||||||||||||||||37995..38022|213|n , number of samples tested .||||||||38901..39108|214|Figure 4 : ( a ) IL-10-mediated phosphorylation of signal transducer and activator of transcription ( STAT ) 1 and STAT3 in CD4 + T cells from patients with rheumatoid arthritis ( RA ) and from healthy controls ( HC ) .|||||||||||||
EntRel||||||||||||||||||||||38901..39108|214|Figure 4 : ( a ) IL-10-mediated phosphorylation of signal transducer and activator of transcription ( STAT ) 1 and STAT3 in CD4 + T cells from patients with rheumatoid arthritis ( RA ) and from healthy controls ( HC ) .||||||||36627..36780|215|CD4 + T cells ( 5 × 105 cells in 0.5 ml culture medium with 10 % FCS ) were incubated with or without IL-10 ( 1 and 10 ng/ml ) and cells were harvested 20 min later .|||||||||||||
Implicit|||||||||||Expansion|||||||||||36627..36780|215|CD4 + T cells ( 5 × 105 cells in 0.5 ml culture medium with 10 % FCS ) were incubated with or without IL-10 ( 1 and 10 ng/ml ) and cells were harvested 20 min later .||||||||39270..39430|216|Whole cell extracts were prepared by placing cells in SDS buffer , and tyrosine phosophorylation ( p-Tyr ) of STAT1 and STAT3 was detected by western blot analysis .|||||||||||||
EntRel||||||||||||||||||||||39270..39430|216|Whole cell extracts were prepared by placing cells in SDS buffer , and tyrosine phosophorylation ( p-Tyr ) of STAT1 and STAT3 was detected by western blot analysis .||||||||14437..14522|217|IFN-γ-stimulated Hela cells were used as a positive control for STAT1 phosphorylation .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14437..14522|217|IFN-γ-stimulated Hela cells were used as a positive control for STAT1 phosphorylation .||||||||39519..39619|218|( b ) Percentage of IL-10-activated STAT3 phosphorylation in CD4 + T cells from RA patients and from HC .|||||||||||||
Implicit|||||||||||Expansion|||||||||||39519..39619|218|( b ) Percentage of IL-10-activated STAT3 phosphorylation in CD4 + T cells from RA patients and from HC .||||||||14288..14425|219|Protein bands were quantified by densitometry using NIH-Image analysis , and STAT3 phosphorylation was expressed as % total STAT3 protein .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14288..14425|219|Protein bands were quantified by densitometry using NIH-Image analysis , and STAT3 phosphorylation was expressed as % total STAT3 protein .||||||||39759..39820|220|( c ) STAT3 phosphorylation in ST CD4 + T cells from RA patients .|||||||||||||
Implicit|||||||||||Expansion|||||||||||39759..39820|220|( c ) STAT3 phosphorylation in ST CD4 + T cells from RA patients .||||||||39822..39986|221|Representative results of STAT3 phosphorylation in CD4 + T cells from three synovial tissue samples of RA patients and three peripheral blood samples of HC are shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||39822..39986|221|Representative results of STAT3 phosphorylation in CD4 + T cells from three synovial tissue samples of RA patients and three peripheral blood samples of HC are shown .||||||||36987..37035|222|Values are the mean ± standard error of the mean .|||||||||||||
EntRel||||||||||||||||||||||37995..38022|223|n , number of samples tested .||||||||40068..40235|224|Figure 5 : ( a ) Activation of signal transducer and activator of transcription ( STAT ) 3 in normal CD4 + T cells by serum IL-6 from patients with rheumatoid arthritis ( RA ) .|||||||||||||
EntRel||||||||||||||||||||||40068..40235|224|Figure 5 : ( a ) Activation of signal transducer and activator of transcription ( STAT ) 3 in normal CD4 + T cells by serum IL-6 from patients with rheumatoid arthritis ( RA ) .||||||||9932..10150|225|CD4 + T cells from healthy controls ( 5 × 105 cells in 0.5 ml culture medium ) were stimulated by 30 % RA serum in the presence of neutralizing anti-IL-6 antibody ( Ab ) ( 40 μg / ml ) or of control antibody ( 40 μg / ml ) for 20 min .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9932..10150|225|CD4 + T cells from healthy controls ( 5 × 105 cells in 0.5 ml culture medium ) were stimulated by 30 % RA serum in the presence of neutralizing anti-IL-6 antibody ( Ab ) ( 40 μg / ml ) or of control antibody ( 40 μg / ml ) for 20 min .||||||||40458..40531|226|Phosophorylation of STAT1 and STAT3 was detected by western blot analysis .|||||||||||||
Implicit|||||||||||Expansion|||||||||||40458..40531|226|Phosophorylation of STAT1 and STAT3 was detected by western blot analysis .||||||||40532..40619|227|( b ) Effect of IL-6 pretreatment on IL-10 inhibition of IFN-γ production by CD4 + T cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||40532..40619|227|( b ) Effect of IL-6 pretreatment on IL-10 inhibition of IFN-γ production by CD4 + T cells .||||||||36627..36875|228|CD4 + T cells ( 5 × 105 cells in 0.5 ml culture medium with 10 % FCS ) were incubated with or without IL-6 ( 10 ng/ml ) for 36 hours , and were then stimulated by anti-CD3 antibody and anti-CD28 antibody in the presence or absence of IL-10 ( 1 ng/ml ) for 36 hours .|||||||||||||
Implicit|||||||||||Expansion|||||||||||36627..36875|228|CD4 + T cells ( 5 × 105 cells in 0.5 ml culture medium with 10 % FCS ) were incubated with or without IL-6 ( 10 ng/ml ) for 36 hours , and were then stimulated by anti-CD3 antibody and anti-CD28 antibody in the presence or absence of IL-10 ( 1 ng/ml ) for 36 hours .||||||||10865..10950|229|Concentrations of IFN-γ in culture supernatants were measured in duplicate by ELISA .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10865..10950|229|Concentrations of IFN-γ in culture supernatants were measured in duplicate by ELISA .||||||||16053..16131|230|IFN-γ production with IL-10 was expressed as % IFN-γ production without IL-10 .|||||||||||||
EntRel||||||||||||||||||||||16053..16131|230|IFN-γ production with IL-10 was expressed as % IFN-γ production without IL-10 .||||||||36987..37035|231|Values are the mean ± standard error of the mean .|||||||||||||
Implicit|||||||||||Expansion|||||||||||36987..37035|231|Values are the mean ± standard error of the mean .||||||||37995..38022|232|n , number of samples tested .|||||||||||||
EntRel||||||||||||||||||||||41121..41153|233|P-Tyr , tyrosine phosophorylation .||||||||41156..41272|234|Figure 6 : ( a ) The mRNA expression of SOCS1 and SOCS3 in CD4 + T cells from patients with RA and healthy controls ( HC ) .|||||||||||||
EntRel||||||||||||||||||||||41156..41272|234|Figure 6 : ( a ) The mRNA expression of SOCS1 and SOCS3 in CD4 + T cells from patients with RA and healthy controls ( HC ) .||||||||11226..11397|235|Total cellular RNA was extracted from freshly isolated CD4 + T cells and mRNA expression of SOCS1 and SOCS3 was analyzed by real time-PCR as described in Patients and Methods .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11226..11397|235|Total cellular RNA was extracted from freshly isolated CD4 + T cells and mRNA expression of SOCS1 and SOCS3 was analyzed by real time-PCR as described in Patients and Methods .||||||||41449..41527|236|Levels of SOCS1 and SOCS3 mRNAs were normalized relative to β-actin expression .|||||||||||||
EntRel||||||||||||||||||||||41449..41527|236|Levels of SOCS1 and SOCS3 mRNAs were normalized relative to β-actin expression .||||||||41529..41554|237|Values are the mean ± SEM .|||||||||||||
EntRel||||||||||||||||||||||41529..41554|237|Values are the mean ± SEM .||||||||41556..41584|238|n = number of samples tested .|||||||||||||
Implicit|||||||||||Expansion|||||||||||41556..41584|238|n = number of samples tested .||||||||41586..41659|239|( b ) Kinetics of IL-6-induced SOCS1 mRNA expression in normal CD4 + T cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||41586..41659|239|( b ) Kinetics of IL-6-induced SOCS1 mRNA expression in normal CD4 + T cells .||||||||41661..41856|240|CD4 + T cells from HC ( 5 × 105 cells in 0.5 ml of culture medium with 10 % FCS ) were stimulated with IL-6 ( 10 ng/ml ) and SOCS1 mRNA expression was determined at the indicated time after stimulation .|||||||||||||
